World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
34270
World Ranking
16416
National Ranking
8258

Overview

Carlos G. Grijalva is affiliated with Vanderbilt University Medical Center in the United States. Their scholarly work primarily focuses on medicine, with significant contributions in epidemiology and infectious diseases. Additional areas of their research include modeling and simulation, health, and environmental and occupational public health.

The main topics explored in their research encompass SARS-CoV-2 and COVID-19, respiratory viral infections, pneumonia and respiratory infections, as well as influenza virus studies. They have also contributed extensively to COVID-19 clinical research and epidemiological studies, including investigations into vaccine coverage and hesitancy.

Frequent collaborators in their research include H. Keipp Talbot, Yuwei Zhu, Natasha Halasa, Wesley H. Self, and James D. Chappell.

The venues where Carlos G. Grijalva most often publishes include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • Open Forum Infectious Diseases
  • MMWR Morbidity and Mortality Weekly Report
  • The Journal of Infectious Diseases

Significant recent papers include:

  • Transmission of SARS-COV-2 Infections in Households - Tennessee and Wisconsin, April-September 2020, 2020, published in MMWR Morbidity and Mortality Weekly Report
  • Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity, 2021, published in JAMA
  • Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study, 2022, published in BMJ
  • Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021, 2021, published in MMWR Morbidity and Mortality Weekly Report
  • Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021, 2021, published in MMWR Morbidity and Mortality Weekly Report

Best Publications

  • Community-acquired pneumonia requiring hospitalization among U.S. adults

    Seema Jain;Derek J. Williams;Sandra R. Arnold;Krow Ampofo

  • The burden of respiratory syncytial virus infection in young children.

    Caroline Breese Hall;Geoffrey A. Weinberg;Marika K. Iwane;Aaron K. Blumkin

  • The Underrecognized Burden of Influenza in Young Children

    Katherine A. Poehling;Kathryn M. Edwards;Geoffrey A. Weinberg;Peter Szilagyi

  • Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

    Carlos G Grijalva;J Pekka Nuorti;Patrick G Arbogast;Stacey W Martin

  • Respiratory Syncytial Virus–Associated Hospitalizations Among Children Less Than 24 Months of Age

    Caroline Breese Hall;Geoffrey A. Weinberg;Aaron K. Blumkin;Kathryn M. Edwards

  • U.S. Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination

    Marie R. Griffin;Yuwei Zhu;Matthew R. Moore;Cynthia G. Whitney

  • Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.

    Mark W Tenforde;Wesley H Self;Katherine Adams;Manjusha Gaglani

  • Antibiotic Prescription Rates for Acute Respiratory Tract Infections in US Ambulatory Settings

    Carlos G. Grijalva;J. Pekka Nuorti;Marie R. Griffin

  • Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis

    You Li;Rachel M Reeves;Xin Wang;Quique Bassat

  • Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.

    Wesley H. Self;Mark W. Tenforde;Jillian P. Rhoads;Manjusha Gaglani;Manjusha Gaglani

  • Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases

    Carlos G. Grijalva;Lang Chen;Elizabeth Delzell;John W. Baddley;John W. Baddley

  • Comparative Effectiveness of Sulfonylurea and Metformin Monotherapy on Cardiovascular Events in Type 2 Diabetes Mellitus: A Cohort Study

    Christianne L. Roumie;Adriana M. Hung;Robert A. Greevy;Carlos G. Grijalva

  • Healthcare utilization and cost of pneumococcal disease in the United States

    Susan S. Huang;Kristen M. Johnson;G. Thomas Ray;Peter Wroe

  • Prescription Opioid Epidemic and Infant Outcomes

    Stephen W. Patrick;Judith Dudley;Peter R. Martin;Frank E. Harrell

  • Respiratory Viral Detection in Children and Adults: Comparing Asymptomatic Controls and Patients With Community-Acquired Pneumonia

    Wesley H. Self;Derek J. Williams;Yuwei Zhu;Krow Ampofo

  • Emergence of parapneumonic empyema in the USA

    Carlos G Grijalva;Yuwei Zhu;J Pekka Nuorti;Marie R Griffin

  • National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States

    Carlos G. Grijalva;Katherine A. Poehling;J. Pekka Nuorti;Yuwei Zhu

  • Increasing Incidence of Empyema Complicating Childhood Community-Acquired Pneumonia in the United States

    Carlos G. Grijalva;J. Pekka Nuorti;Yuwei Zhu;Marie R. Griffin

  • Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021.

    Mark W. Tenforde;Samantha M. Olson;Wesley H. Self;H. Keipp Talbot

  • Reduction of Frequent Otitis Media and Pressure-Equalizing Tube Insertions in Children After Introduction of Pneumococcal Conjugate Vaccine

    Katherine A. Poehling;Peter G. Szilagyi;Carlos G. Grijalva;Stacey W. Martin

Frequent Co-Authors

Marie R. Griffin
Marie R. Griffin Vanderbilt University Medical Center
Kathryn M. Edwards
Kathryn M. Edwards Vanderbilt University Medical Center
Jonathan A. McCullers
Jonathan A. McCullers University of Tennessee Health Science Center
Evan J. Anderson
Evan J. Anderson Emory University
Richard G. Wunderink
Richard G. Wunderink Northwestern University
Andrew T. Pavia
Andrew T. Pavia University of Utah
John V. Williams
John V. Williams University of Pittsburgh
Natasha Halasa
Natasha Halasa Vanderbilt University Medical Center
Samir S. Shah
Samir S. Shah Cincinnati Children's Hospital Medical Center
James D. Chappell
James D. Chappell Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees in healthcare can open many doors for those interested in Medicine in the USA. For those passionate about food science and wellness, an online bachelor's degree in nutrition offers flexible learning for a career in dietetics or health education.

Aspiring leaders in healthcare systems might consider top cahme accredited mha programs. These programs are recognized for their rigorous standards in healthcare administration, preparing graduates to manage hospitals, clinics, and other medical organizations.

Registered Nurses looking to advance without in-person clinicals can opt for online rn-bsn programs without clinicals. These degrees are designed for working nurses, offering an efficient path to career growth.

For those aiming for the highest level of clinical nursing practice, the quickest dnp program options help nurses earn a doctoral degree with minimal time away from their current roles.

Each of these pathways provides unique opportunities to advance in the ever-evolving field of healthcare, with the convenience and flexibility of online learning.

Best Scientists Citing Carlos G. Grijalva

Trending Scientists

Recently Published Articles